{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:29:10Z","timestamp":1784388550681,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130036"],"award-info":[{"award-number":["82130036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171310, 82371326"],"award-info":[{"award-number":["82171310, 82371326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"STI2030-Major Project","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}]},{"name":"Jiangsu Province Key Medical Discipline","award":["ZDXK202216"],"award-info":[{"award-number":["ZDXK202216"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240118"],"award-info":[{"award-number":["BK20240118"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03575-9","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:38:13Z","timestamp":1751690293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Macrophage-mimetic liposomes co-delivering ceria and Ac2-26 peptide for penumbra protection in ischemic stroke"],"prefix":"10.1186","volume":"23","author":[{"given":"Lingyun","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dujuan","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"issue":"15","key":"3575_CR1","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2023.07.025","volume":"82","author":"A Greco","year":"2023","unstructured":"Greco A, Occhipinti G, Giacoppo D, Agnello F, Laudani C, Spagnolo M, Mauro MS, Rochira C, Finocchiaro S, Mazzone PM, et al. Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC State-of-the-Art review. J Am Coll Cardiol. 2023;82(15):1538\u201357.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"3575_CR2","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/eurheartj\/ehv140","volume":"36","author":"RD Spescha","year":"2015","unstructured":"Spescha RD, Klohs J, Semerano A, Giacalone G, Derungs RS, Reiner MF, Rodriguez Gutierrez D, Mendez-Carmona N, Glanzmann M, Savarese G, et al. Post-ischaemic Silencing of p66Shc reduces ischaemia\/reperfusion brain injury and its expression correlates to clinical outcome in stroke. Eur Heart J. 2015;36(25):1590\u2013600.","journal-title":"Eur Heart J"},{"issue":"14","key":"3575_CR3","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/eurheartj\/ehac684","volume":"44","author":"P Widimsky","year":"2023","unstructured":"Widimsky P, Snyder K, Sulzenko J, Hopkins LN, Stetkarova I. Acute ischaemic stroke: recent advances in reperfusion treatment. Eur Heart J. 2023;44(14):1205\u201315.","journal-title":"Eur Heart J"},{"issue":"1","key":"3575_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/01.STR.30.1.93","volume":"30","author":"AM Kaufmann","year":"1999","unstructured":"Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H. Ischemic core and penumbra in human stroke. Stroke. 1999;30(1):93\u20139.","journal-title":"Stroke"},{"issue":"6","key":"3575_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12975-021-00916-2","volume":"12","author":"SH Yang","year":"2021","unstructured":"Yang SH, Liu R. Four decades of ischemic penumbra and its implication for ischemic stroke. Transl Stroke Res. 2021;12(6):937\u201345.","journal-title":"Transl Stroke Res"},{"key":"3575_CR6","doi-asserted-by":"publisher","first-page":"103185","DOI":"10.1016\/j.redox.2024.103185","volume":"73","author":"Z Hou","year":"2024","unstructured":"Hou Z, Brenner JS. Developing targeted antioxidant nanomedicines for ischemic penumbra: novel strategies in treating brain ischemia-reperfusion injury. Redox Biol. 2024;73:103185.","journal-title":"Redox Biol"},{"key":"3575_CR7","doi-asserted-by":"publisher","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","volume":"335","author":"S Paul","year":"2021","unstructured":"Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518.","journal-title":"Exp Neurol"},{"issue":"9","key":"3575_CR8","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1161\/STROKEAHA.121.032241","volume":"52","author":"PD Lyden","year":"2021","unstructured":"Lyden PD. Cerebroprotection for acute ischemic stroke: looking ahead. Stroke. 2021;52(9):3033\u201344.","journal-title":"Stroke"},{"issue":"8","key":"3575_CR9","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.1021\/acsomega.3c03661","volume":"9","author":"Y Bai","year":"2024","unstructured":"Bai Y, Li Y, Li Y, Tian L. Advanced biological applications of cerium oxide nanozymes in disease related to oxidative damage. ACS Omega. 2024;9(8):8601\u201314.","journal-title":"ACS Omega"},{"issue":"3","key":"3575_CR10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1039\/D1RA05407D","volume":"12","author":"N Feng","year":"2022","unstructured":"Feng N, Liu Y, Dai X, Wang Y, Guo Q, Li Q. Advanced applications of cerium oxide based nanozymes in cancer. RSC Adv. 2022;12(3):1486\u201393.","journal-title":"RSC Adv"},{"issue":"1","key":"3575_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-021-02174-3","volume":"18","author":"X Xu","year":"2021","unstructured":"Xu X, Gao W, Li L, Hao J, Yang B, Wang T, Li L, Bai X, Li F, Ren H, et al. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia\/macrophage polarization via FPR2\/ALX-dependent AMPK-mTOR pathway. J Neuroinflammation. 2021;18(1):119.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3575_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12974-020-02006-w","volume":"17","author":"M R\u00fcger","year":"2020","unstructured":"R\u00fcger M, Kipp E, Schubert N, Schr\u00f6der N, Pufe T, Stope MB, Kipp M, Blume C, Tauber SC, Brandenburg LO. The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of Pneumococcal meningitis. J Neuroinflammation. 2020;17(1):325.","journal-title":"J Neuroinflammation"},{"key":"3575_CR13","doi-asserted-by":"crossref","unstructured":"Deutloff J, P\u00f6hner I, R\u00f6\u00dfler J, Kipp M, Tauber SC, Brandenburg LO. The formyl peptid receptor ligand Ac2-26 improves the integrity of the Blood-Brain barrier in the course of Pneumococcal meningitis. Cells. 2024;13(24).","DOI":"10.3390\/cells13242104"},{"issue":"1","key":"3575_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12951-024-02772-2","volume":"22","author":"W Liu","year":"2024","unstructured":"Liu W, Liu L, Li H, Xie Y, Bai J, Guan J, Qi H, Sun J. Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system. J Nanobiotechnol. 2024;22(1):499.","journal-title":"J Nanobiotechnol"},{"key":"3575_CR15","doi-asserted-by":"crossref","unstructured":"Toljan K, Ashok A, Labhasetwar V, Hussain MS. Nanotechnology in stroke: new trails with smaller scales. Biomedicines. 2023;11(3).","DOI":"10.3390\/biomedicines11030780"},{"key":"3575_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","volume":"360","author":"H Wu","year":"2023","unstructured":"Wu H, Zhang T, Li N, Gao J. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges. J Control Release. 2023;360:169\u201384.","journal-title":"J Control Release"},{"issue":"20","key":"3575_CR17","doi-asserted-by":"publisher","first-page":"e2101526","DOI":"10.1002\/advs.202101526","volume":"8","author":"C Li","year":"2021","unstructured":"Li C, Zhao Z, Luo Y, Ning T, Liu P, Chen Q, Chu Y, Guo Q, Zhang Y, Zhou W, et al. Macrophage-Disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke. Adv Sci (Weinh). 2021;8(20):e2101526.","journal-title":"Adv Sci (Weinh)"},{"issue":"51","key":"3575_CR18","doi-asserted-by":"publisher","first-page":"60852","DOI":"10.1021\/acsami.1c16126","volume":"13","author":"J Kim","year":"2021","unstructured":"Kim J, Hong G, Mazaleuskaya L, Hsu JC, Rosario-Berrios DN, Grosser T, Cho-Park PF, Cormode DP. Ultrasmall antioxidant cerium oxide nanoparticles for regulation of acute inflammation. ACS Appl Mater Interfaces. 2021;13(51):60852\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"26","key":"3575_CR19","doi-asserted-by":"publisher","first-page":"e2201280","DOI":"10.1002\/smll.202201280","volume":"18","author":"J Che","year":"2022","unstructured":"Che J, Sun L, Shan J, Shi Y, Zhou Q, Zhao Y, Sun L. Artificial lipids and macrophage membranes coassembled biomimetic nanovesicles for antibacterial treatment. Small. 2022;18(26):e2201280.","journal-title":"Small"},{"issue":"26","key":"3575_CR20","doi-asserted-by":"publisher","first-page":"16450","DOI":"10.1021\/acsnano.4c03425","volume":"18","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li Z, Fan X, Jiang C, Wang J, Rastegar-Kashkooli Y, Wang TJ, Wang J, Wang M, Cheng N, et al. Nanozymes: potential therapies for reactive oxygen species overproduction and inflammation in ischemic stroke and traumatic brain injury. ACS Nano. 2024;18(26):16450\u201367.","journal-title":"ACS Nano"},{"issue":"2","key":"3575_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.pharmthera.2013.12.007","volume":"142","author":"J Navarro-Yepes","year":"2014","unstructured":"Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, Li M, Pappa A, Martinez-Fong D, Del Razo LM, et al. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther. 2014;142(2):206\u201330.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3575_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wan S, Yang S, Hu H, Zhang C, Lai J, Zhou J, Chen W, Tang X, Luo J, et al. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. J Nanobiotechnol. 2022;20(1):542.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"3575_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","volume":"22","author":"G Tsivgoulis","year":"2023","unstructured":"Tsivgoulis G, Katsanos AH, Sandset EC, Turc G, Nguyen TN, Bivard A, Fischer U, Khatri P. Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol. 2023;22(5):418\u201329.","journal-title":"Lancet Neurol"},{"key":"3575_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.redox.2016.12.029","volume":"11","author":"S Sun","year":"2017","unstructured":"Sun S, Hu F, Wu J, Zhang S. Cannabidiol attenuates OGD\/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons. Redox Biol. 2017;11:577\u201385.","journal-title":"Redox Biol"},{"issue":"6","key":"3575_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","volume":"11","author":"A Datta","year":"2020","unstructured":"Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, Veeresh P, Kotian V, Kalia K, Borah A, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res. 2020;11(6):1185\u2013202.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"3575_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"3575_CR27","doi-asserted-by":"crossref","unstructured":"Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, Chen J, Keep RF, Shi Y. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. 2018;163\u20134:144\u201371.","DOI":"10.1016\/j.pneurobio.2017.10.001"},{"key":"3575_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-10-115","volume":"10","author":"NV Gr\u00f8nberg","year":"2013","unstructured":"Gr\u00f8nberg NV, Johansen FF, Kristiansen U, Hasseldam H. Leukocyte infiltration in experimental stroke. J Neuroinflammation. 2013;10:115.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3575_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000321965","volume":"65","author":"R Brouns","year":"2011","unstructured":"Brouns R, Wauters A, De Surgeloose D, Mari\u00ebn P, De Deyn PP. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol. 2011;65(1):23\u201331.","journal-title":"Eur Neurol"},{"key":"3575_CR30","doi-asserted-by":"crossref","unstructured":"Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, Bal W, Pawletko K, Lewin-Kowalik J. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019;70(2).","DOI":"10.1101\/503953"},{"issue":"7","key":"3575_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/jcbfm.2015.38","volume":"35","author":"CD Hue","year":"2015","unstructured":"Hue CD, Cho FS, Cao S, Dale Bass CR, Meaney DF, Morrison B 3rd. Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein. J Cereb Blood Flow Metab. 2015;35(7):1191\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3575_CR32","doi-asserted-by":"crossref","unstructured":"Zhang S, An Q, Wang T, Gao S, Zhou G, Autophagy-. MMP-2\/9-mediated reduction and redistribution of ZO-1 contribute to Hyperglycemia-increased Blood-Brain barrier permeability during early reperfusion in stroke. Neuroscience. 2018;377:126\u201337.","DOI":"10.1016\/j.neuroscience.2018.02.035"},{"issue":"5","key":"3575_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.410410506","volume":"41","author":"AE Baird","year":"1997","unstructured":"Baird AE, Benfield A, Schlaug G, Siewert B, L\u00f6vblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41(5):581\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"3575_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-021-04379-z","volume":"13","author":"M Bellut","year":"2021","unstructured":"Bellut M, Papp L, Bieber M, Kraft P, Stoll G, Schuhmann MK. NLPR3 inflammasome Inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke. Cell Death Dis. 2021;13(1):20.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3575_CR35","doi-asserted-by":"publisher","first-page":"e14462","DOI":"10.1111\/cns.14462","volume":"30","author":"G Fadoul","year":"2024","unstructured":"Fadoul G, Ikonomovic M, Zhang F, Yang T. The cell-specific roles of Nrf2 in acute and chronic phases of ischemic stroke. CNS Neurosci Ther. 2024;30(3):e14462.","journal-title":"CNS Neurosci Ther"},{"key":"3575_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.freeradbiomed.2016.02.009","volume":"94","author":"X Duan","year":"2016","unstructured":"Duan X, Li J, Li W, Xing X, Zhang Y, Li W, Zhao L, Sun G, Gao XH, Li B. Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes. Free Radic Biol Med. 2016;94:74\u201387.","journal-title":"Free Radic Biol Med"},{"key":"3575_CR37","doi-asserted-by":"publisher","first-page":"118684","DOI":"10.1016\/j.jep.2024.118684","volume":"336","author":"NS Bangar","year":"2025","unstructured":"Bangar NS, Dixit A, Apte MM, Tupe RS. Syzygium cumini (L.) Skeels mitigate diabetic nephropathy by regulating Nrf2 pathway and mitocyhondrial dysfunction: in vitro and in vivo studies. J Ethnopharmacol. 2025;336:118684.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"3575_CR38","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1007\/s12035-024-04092-w","volume":"61","author":"W Yan","year":"2024","unstructured":"Yan W, Wang C, Zhao Y, Jiang Y, Sun M. Involvement of Calpain in neurovascular unit damage through Up-regulating PARP-NF-\u03baB signaling during experimental ischemic stroke. Mol Neurobiol. 2024;61(10):8104\u201322.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"3575_CR39","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1007\/s12035-023-03318-7","volume":"60","author":"L Deng","year":"2023","unstructured":"Deng L, Zhang J, Chen S, Wu Y, Fan X, Zuo T, Hu Q, Jiang L, Yang S, Dong Z. miR-671-5p upregulation attenuates Blood-Brain barrier disruption in the ischemia stroke model via the NF-\u043aB\/MMP-9 signaling pathway. Mol Neurobiol. 2023;60(7):3824\u201338.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"3575_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/glia.24146","volume":"70","author":"X Qin","year":"2022","unstructured":"Qin X, Wang J, Chen S, Liu G, Wu C, Lv Q, He X, Bai X, Huang W, Liao H. Astrocytic p75(NTR) expression provoked by ischemic stroke exacerbates the blood-brain barrier disruption. Glia. 2022;70(5):892\u2013912.","journal-title":"Glia"},{"key":"3575_CR41","doi-asserted-by":"crossref","unstructured":"Lee DY, Yun SM, Song MY, Jung K, Kim EH. Cyanidin chloride induces apoptosis by inhibiting NF-\u03baB signaling through activation of Nrf2 in colorectal Cancer cells. Antioxid (Basel). 2020;9(4).","DOI":"10.3390\/antiox9040285"},{"issue":"7","key":"3575_CR42","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41418-020-0496-1","volume":"27","author":"E Sanchez-Lopez","year":"2020","unstructured":"Sanchez-Lopez E, Ghia EM, Antonucci L, Sharma N, Rassenti LZ, Xu J, Sun B, Kipps TJ, Karin M. NF-\u03baB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia. Cell Death Differ. 2020;27(7):2206\u201316.","journal-title":"Cell Death Differ"},{"issue":"3","key":"3575_CR43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/bph.15961","volume":"180","author":"J Gao","year":"2023","unstructured":"Gao J, Ma C, Xia D, Chen N, Zhang J, Xu F, Li F, He Y, Gong Q. Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS\/NF-\u03baB\/ferroptosis pathway. Br J Pharmacol. 2023;180(3):308\u201329.","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03575-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:38:16Z","timestamp":1751690296000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03575-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3575"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03575-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the ARRIVE guidelines and were approved by the Institutional Animal Care and Use Committee of the Affiliated Drum Tower Hospital, Nanjing University (Ethical Approval No.: 2023AE01034). All methods were performed in compliance with relevant institutional and national guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this study agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}